Physician profile
James Rothstein
NPI 1265419584
$6,726.87
in general payments reported to CMS, 2019-2025
29 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $551 · 2020: $555 · 2021: $1,162 · 2022: $685 · 2023: $1,991 · 2024: $1,677 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,586 · Food and Beverage: $1,189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,585.62 |
| Food and Beverage | $1,188.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,075.86 | 2023-2024 | Indigo System, Penumbra System |
| Bard Peripheral Vascular, INC. | $1,484.34 | 2020-2024 | Crosser Iq |
| Abbott Laboratories | $733.47 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Angiodynamics, INC. | $707.90 | 2021-2022 | |
| Cook Medical LLC | $571.01 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $266.59 | 2020-2024 | Xarelto |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $110.17 | 2019-2020 | |
| Boston Scientific Corporation | $87.04 | 2024-2025 | Bodyguardian, General - Therapies |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $80.16 | 2023-2024 | Lifevest |
| Philips North America LLC | $69.70 | 2020 | |
| Cardiovascular Systems INC. | $68.49 | 2022 | |
| Novo Nordisk INC | $57.58 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Regeneron Healthcare Solutions, INC. | $48.74 | 2019 | |
| Shockwave Medical, INC | $41.03 | 2019-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cvrx, INC. | $40.16 | 2024 | Barostim Neo System |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $36.35 | 2024 | |
| Tactile Systems Technology INC | $30.40 | 2019-2022 | |
| Terumo Medical Corporation | $25.48 | 2022 | |
| Medtronic Vascular, INC. | $23.63 | 2019 | |
| Inspire Medical Systems, INC. | $23.36 | 2025 | Inspire |
| Venturemed Group, INC. | $20.50 | 2021 | |
| Inari Medical, INC. | $18.15 | 2022 | |
| Normatec Industries, Lp | $18.00 | 2019 | |
| Celonova Biosciences, INC. | $17.13 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $16.72 | 2024 | Arcalyst |
| Lilly USA, LLC | $16.06 | 2025 | Zepbound |
| Smith+Nephew, INC. | $15.06 | 2020 | |
| Kerecis Limited | $13.99 | 2022 | |
| Merit Medical Systems INC | $9.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Rothstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.